(PDN) FTSE RAFI Developed Markets - Overview
Etf: Small-Cap Stocks, Mid-Cap Stocks, Developed Markets, Non-US
Dividends
| Dividend Yield | 3.63% |
| Yield on Cost 5y | 4.54% |
| Yield CAGR 5y | 12.34% |
| Payout Consistency | 90.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.7% |
| Relative Tail Risk | 0.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.10 |
| Alpha | 32.08 |
| Character TTM | |
|---|---|
| Beta | 0.608 |
| Beta Downside | 0.585 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.25% |
| CAGR/Max DD | 1.32 |
Description: PDN FTSE RAFI Developed Markets January 10, 2026
The Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF (NYSE ARCA: PDN) seeks to replicate an index of roughly 1,500 non-U.S. small- and mid-cap stocks, allocating at least 90 % of assets to the index constituents. The index is weighted by four fundamental size measures-book value plus intangibles, adjusted cash flow, adjusted sales, and dividend-plus-buybacks-aiming to capture value-oriented exposure in developed markets outside the United States.
Key quantitative points (as of the latest filing) include an expense ratio of 0.35 %, a weighted-average market capitalization of about $2.5 billion, and an annualized dividend yield near 1.8 %. The top sector allocations are financials (~22 %), industrials (~18 %), and consumer discretionary (~15 %). Recent performance is closely tied to global GDP growth expectations and the prevailing interest-rate environment, which tend to amplify earnings volatility for smaller-cap companies.
For a deeper, data-driven look at PDN’s valuation profile, the ValueRay platform provides a concise, interactive dashboard you may find useful.
What is the price of PDN shares?
Over the past week, the price has changed by +1.92%, over one month by +5.77%, over three months by +12.03% and over the past year by +42.56%.
Is PDN a buy, sell or hold?
What are the forecasts/targets for the PDN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 53.2 | 16.6% |
PDN Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 377.3m USD (377.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 377.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 377.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.15% (E(377.3m)/V(377.3m) * Re(8.15%) + (debt-free company))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)